Clinical TrialsSearch results
Number of results: 67160
Completed
- A multicenter, open-label study investigating efficacy and safety of GB-0998 for antibody-mediated rejection after renal transplant
- AMR after renal transplant
- Nakagawa Ken
- 2020-10-28
Completed
- A multicenter, open-label, randomized controlled phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19
- COVID-19
- Sugiyama Haruhito
- 2020-03-27
Completed
- A Multicenter, Open-label, Uncontrolled Phase II study of ONO-4538 [immune-checkpoint inhibitor] for cutaneous angiosarcoma
- Advanced or recurrent cutaneous hemangiosarcoma
- Fujisawa Yasuhiro
- 2020-04-22
Completed
- A Multicenter, Prospective, Open Label, Single-Arm Study of a Novel Pain Management Device, AT-04, in Patients with Acute Low Back Pain
- Acute Low Back Pain
- Miki Kenji
- 2020-02-13
Completed
- A Multicenter, Prospective, Randomized Controlled Trial: SMC-01: A Mobile Medical Application to Improve Self-Management of Patients with Type 2 Diabetes
- Type 2 Diabetes
- Ohnishi Yukiko
- 2020-05-17
Completed
- A Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis
- Eosinophilic Esophagitis
- Hibi Kazushige
- 2020-11-04
Completed
- A multicenter, randomized, double-blind, placebo controlled Phase 3 study of remibrutinib (LOU064) to investigate the efficacy, safety and tolerability for 52 weeks in adult chronic spontaneous urticaria patients inadequately controlled by H1-antihistamines
- chronic spontaneous urticaria
- Maruyama Hideki
- 2021-11-02
Completed
- A multicenter, randomized, open-label, parallel-group study of EN-P11 in patients with enteral tube feeding.
- Patients with enteral tube feeding.
- Michio Maruyama
- 2023-06-27
Completed
- A New Phototubometry
- External and middle ear diseases
- Yazama Hiroaki
- 2019-05-29
Completed
- A Non Interventional Pilot Study on Machine Learning for ILD detection based on the patient data from digital devices in unresectable stage III Non-Small Cell Lung Cancer Patients receiving durvalumab
- Non-Small Cell Lung Cancer
- Kouda Shigetaka
- 2021-06-02